← Back to Search

Other

BFR deflate for Anterior Cruciate Ligament Reconstruction Rehabilitation

N/A
Waitlist Available
Research Sponsored by Richard Watson, PT
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24th visit or 12 weeks post-op (if missed appointments)
Awards & highlights

Study Summary

This trial is testing whether or not deflating the blood flow restrictive (BFR) cuff between exercises results in greater quadriceps strength and functional outcomes after MPFL or ACL reconstruction, as well as reduced pain and improved exercise tolerance.

Eligible Conditions
  • Medial Patellofemoral Ligament Reconstruction Rehabilitation
  • Anterior Cruciate Ligament Reconstruction Rehabilitation

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24th visit or 12 weeks post-op (if missed appointments)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24th visit or 12 weeks post-op (if missed appointments) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
2000 IKDC Subjective Knee Evaluation Form
Ability to in-line jog
Brief Resiliency Scale
+7 more
Secondary outcome measures
Discomfort level
Effort Level

Trial Design

2Treatment groups
Active Control
Group I: BFR deflateActive Control1 Intervention
BFR cuff will be deflated at the end of each of the 4 BFR exercises, BFR cuff is inflated prior to start next BFR exercise.
Group II: BFR do not deflateActive Control1 Intervention
BFR cuff will not be deflated at the end of each of the 4 BFR exercises. Cuff remains inflated start exercise 1 thru completion exercise 4.

Find a Location

Who is running the clinical trial?

Richard Watson, PTLead Sponsor

Media Library

Rehabilitation utilizing blood flow restrictive therapy (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05426954 — N/A
Anterior Cruciate Ligament Reconstruction Rehabilitation Research Study Groups: BFR deflate, BFR do not deflate
Anterior Cruciate Ligament Reconstruction Rehabilitation Clinical Trial 2023: Rehabilitation utilizing blood flow restrictive therapy Highlights & Side Effects. Trial Name: NCT05426954 — N/A
Rehabilitation utilizing blood flow restrictive therapy (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05426954 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any participation openings in this research currently available?

"Affirmative. Clinicaltrials.gov records the status of this clinical trial as open, with an initial post date on June 29th 2021 and recent update dated June 16th 2022. The study is in need of 32 participants at one site specifically."

Answered by AI

How many participants have joined this trial thus far?

"Indeed, current details on clinicaltrials.gov demonstrate that this study is actively searching for participants. It was initially posted to the site on June 29th 2021 and updated most recently in mid-June of 2022. 32 patients need to be enrolled from one location."

Answered by AI

Is there an age limit on joining this particular experiment?

"The requirements for enrolment into this experiment indicate that individuals aged between 13 and 40 are eligible to participate."

Answered by AI

To what extent is enrollment in this trial open to the public?

"For this trial, 32 individuals aged 13 to 40 with current medial patellar femoral ligament reconstruction rehab are being sought out. Furthermore, these participants must meet requirements for post-operative Medial Patellar Femoral Ligament or Anterior Cruciate Ligament Reconstruction."

Answered by AI
~11 spots leftby Apr 2025